- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q1 2026 · Mar 31, 2026 | $556K |
| Capex | Q1 2026 · Mar 31, 2025 | $22K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$22.34M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $28.98M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $150.33M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $137.53M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $89.07M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $72.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $35.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $17.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $42.96M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $56.27M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $90.94M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $119.41M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $154.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $145.03M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $163.49M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $154.69M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.58 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.58 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.49 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.93M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $8.52M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $19.83M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $8.27M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$9.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$13.27M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$14.11M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$13.85M |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.65M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.93M |